Neuronetics, Inc. (STIM) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $762.00K; Additional Paid in Capital, Common StockUSD $490.24M; Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD $-473.15M.
- 2026-03-31: Common Stock, Value, IssuedUSD $696.00K; Additional Paid in Capital, Common StockUSD $482.15M; Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD $-469.58M.
- 2025-12-31: Common Stock, Value, IssuedUSD $690.00K; Additional Paid in Capital, Common StockUSD $480.48M; Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD $-458.79M.
- 2025-09-30: Common Stock, Value, IssuedUSD $685.00K; Additional Paid in Capital, Common StockUSD $478.30M; Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD $-451.63M.
Neuronetics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $762.00K | $490.24M | (m) | $-473.15M | $17.85M | $21.64M | (m) | 3 month · $688.00K | (m) |
| 2026-03-31 | $696.00K | $482.15M | (m) | $-469.58M | $13.27M | $17.06M | (m) | 3 month · $1.68M | (m) |
| 2025-12-31 | $690.00K | $480.48M | (m) | $-458.79M | $22.38M | $26.24M | (m) | 12 month · $6.85M | (m) |
| 2025-09-30 | $685.00K | $478.30M | (m) | $-451.63M | $27.36M | $31.36M | 3 month · $472.00K | 3 month · $1.41M | (m) |
| 2025-06-30 | $661.00K | $469.07M | (m) | $-442.58M | $27.15M | $31.51M | (m) | 3 month · $1.81M | (m) |
| 2025-03-31 | $658.00K | $467.26M | (m) | $-432.46M | $35.45M | $39.53M | 3 month · $1.73M | 3 month · $1.44M | (m) |
| 2024-12-31 | $557.00K | $446.94M | (m) | $-419.79M | $27.71M | $31.80M | 12 month · $49.00K | 12 month · $5.60M | 12 month · $2.52M |
| 2024-09-30 | $121.24M | $416.20M | $5.51M | $-263.66M | $-136.92M | $9.38M | 3 month · $35.00K | 3 month · $1.42M | 3 month · $1.92M |
| 2024-06-30 | $301.00K | $412.87M | (m) | $-393.79M | $19.39M | $19.39M | (m) | 3 month · $1.56M | (m) |
| 2024-03-31 | $300.00K | $411.31M | (m) | $-383.95M | $27.66M | $27.66M | (m) | 3 month · $1.34M | (m) |
| 2023-12-31 | $291.00K | $409.98M | $5.40M | $-376.08M | $34.19M | $34.19M | (m) | 12 month · $7.32M | (m) |
| 2023-09-30 | $289.00K | $408.36M | (m) | $-370.70M | $37.94M | $-88.88M | (m) | 3 month · $14.74K | 3 month · $19.35K |
| 2023-06-30 | $288.00K | $406.50M | (m) | $-361.31M | $45.48M | $-75.85M | (m) | 3 month · $513.78K | (m) |
| 2023-03-31 | $285.00K | $404.47M | (m) | $-356.41M | $48.34M | $-63.51M | (m) | 3 month · $62.95K | 3 month · $59.79K |
| 2022-12-31 | $273.00K | $402.68M | (m) | $-345.89M | $57.06M | $57.06M | (m) | 12 month · $8.75M | (m) |
| 2022-09-30 | $270.00K | $400.32M | (m) | $-337.60M | $62.99M | (m) | (m) | 3 month · $2.18M | (m) |
| 2022-06-30 | $268.00K | $398.15M | (m) | $-329.99M | $68.42M | (m) | (m) | 3 month · $2.20M | (m) |
| 2022-03-31 | $267.00K | $395.90M | (m) | $-319.57M | $76.60M | (m) | (m) | 3 month · $2.25M | (m) |
| 2021-12-31 | $264.00K | $393.64M | (m) | $-308.73M | $85.17M | $85.17M | (m) | 12 month · $7.87M | (m) |
| 2021-09-30 | $263.00K | $391.91M | (m) | $-301.10M | $91.08M | (m) | (m) | 3 month · $1.96M | (m) |
| 2021-06-30 | $262.00K | $389.85M | (m) | $-292.95M | $97.17M | (m) | (m) | 3 month · $2.01M | (m) |
| 2021-03-31 | $258.00K | $387.13M | (m) | $-285.42M | $101.97M | (m) | (m) | 3 month · $2.20M | (m) |
| 2020-12-31 | $191.00K | $302.84M | (m) | $-277.54M | $25.49M | (m) | (m) | 12 month · $4.40M | (m) |
| 2020-09-30 | $189.00K | $301.17M | (m) | $-273.88M | $27.48M | (m) | (m) | 3 month · $1.05M | (m) |
| 2020-06-30 | $188.00K | $299.72M | (m) | $-270.46M | $29.44M | (m) | (m) | 3 month · $646.00K | (m) |
| 2020-03-31 | $187.00K | $299.02M | (m) | $-262.70M | $36.51M | (m) | (m) | 3 month · $1.20M | (m) |
| 2019-12-31 | $186.00K | $297.75M | (m) | $-250.09M | $47.85M | (m) | (m) | 12 month · $3.43M | (m) |
| 2019-09-30 | $186.00K | $296.68M | (m) | $-242.53M | $54.33M | (m) | (m) | 3 month · $935.00K | (m) |
| 2019-06-30 | $184.00K | $295.30M | (m) | $-235.67M | $59.82M | (m) | (m) | 3 month · $1.02M | (m) |
| 2019-03-31 | $182.00K | $293.81M | (m) | $-228.57M | $65.42M | (m) | (m) | 3 month · $501.00K | (m) |
| 2018-12-31 | $177.00K | $291.91M | (m) | $-221.04M | $71.04M | (m) | (m) | 12 month · $1.74M | (m) |
| 2018-09-30 | $176.00K | $291.07M | (m) | $-214.90M | $76.35M | (m) | (m) | 3 month · $1.03M | (m) |
| 2018-06-30 | $3.00K | $4.67M | (m) | $-209.94M | $-205.27M | (m) | (m) | 3 month · $192.00K 6 month · $336.00K | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | $-197.97M | (m) | (m) | 3 month · $144.00K | (m) |
| 2017-12-31 | $2.00K | $4.29M | (m) | $-196.95M | $-192.65M | (m) | (m) | 12 month · $496.00K | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | $-177.12M | (m) | (m) | 12 month · $161.00K | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | $-166.12M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |